Pharmaceuticals & Biotechnology • Mid Cap

Glenmark Pharmaceuticals Ltd.

₹2,640.00▼ 19.80 (0.74%)

Open Trading A/c

Updated Nov 13, 2026, 3:30PM

Prev. Close₹2,659.80▼ 0.74%

Open₹2,657.80▼ 0.67%

Invest in this Stock with SMC GlobalStart Now

Performance

LowHigh

2,628.602,679.90

52W Low52W High

1,810.002,714.00

Turnover₹116.39 Cr

Volume Traded4.41L

P/E Ratio—

Market Cap₹58951.75 Cr

Avg. Volume8.46L

Stories & Reports

Stocks To Watch Today: LIC, ONGC, Britannia Industries, Bharti Airtel, Titan, Glenmark Pharma & More

Five Stocks To Buy Today, November 03: Glenmark Pharma, Tata Power, BPCL And More

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth

Five Stocks To Buy Today: State Bank of India, HAL, Glenmark Pharma, And More | Sept 9

Buy, Sell Or Hold: Vishal Mega Mart, HDFC Bank, Shriram Finance, Ather Energy And Glenmark Pharma — Ask Profit

Stocks To Buy Today: Coforge, Timex To Glenmark Pharma — Five Stock Picks By Motilal Oswal's Chandan Taparia

V/S

Glenmark Pharmaceuticals Ltd.-19.80 (0.74%)NIFTY 50-155.05 (0.61%)

Announcements

Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet

View Full Doc

Glenmark Pharmaceuticals Ltd. Share Price

As of 14 November 2026, Glenmark Pharmaceuticals Ltd. share price is ₹2,640.00. The stock opened at ₹2,657.80, compared to its previous close of ₹2,659.80. During today's trading session, Glenmark Pharmaceuticals Ltd. share price moved in the range of ₹2,628.60 to ₹2,679.90.

Looking at its last 52-week performance, the stock has touched a low of ₹1,810.00 and a high of ₹2,714.00. On the performance front, Glenmark Pharmaceuticals Ltd. share price is up 40.38% on a year-on-year basis.

The market capitalization of Glenmark Pharmaceuticals Ltd. is ₹58951.75 Cr.